Sümeyra Kılıç
Research Subjects
Sümeyra Kılıç has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Gürkan Tarçın
Kocaeli University Medical Faculty, Department of Pediatric Endocrinology, Kocaeli, Türkiye
2 shared publications - Semine Özdemir Dilek
Adana Sehır Araştırma Hastanesi
2 shared publications - Aysun Ata
Department of Pediatric Endocrinology, Faculty of Medicine, Ege University, İzmir, Türkiye
1 shared publication - Meltem Erdem
UNIVERSITY OF HEALTH SCIENCES, ADANA NUMUNE HEALTH RESEARCH CENTER
1 shared publication - Mevra Cay
Çukurova University
1 shared publication - Seyit Ahmet Uçaktürk
Department of Pediatric Endocrinology, Adana City Hospital, University of Health Sciences, Adana, Türkiye
1 shared publication
Latest Publications
- 29 June 2026
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 51 (2) , 567-576
Clinical utility of the SPISE index as an indicator of insulin resistance in pediatric obesity
Purpose: Single Point Insulin Sensitivity Estimator (SPISE) index is a lipid-based marker of insulin sensitivity, but data on its role in pediatric obesity are limited. This study evaluated its performance in identifying metabolic syndrome (MetS) and related metabolic risk factors in children and adolescents with obesity.Materials and Methods: In this retrospective study, anthropometric and laboratory data were collected, and the SPISE index was calculated based on BMI, triglyceride, and HDL cholesterol levels. Correlation analyses and receiver operating characteristic (ROC) analyses were performed to assess the association of SPISE with metabolic parameters and its performance, compared with HOMA-IR, in detecting MetS.Results: A total of 213 participants (58.7% female) with a mean age of 12.6 ± 3.2 years were included. The SPISE index showed inverse correlations with BMI SDS (r = −0.714), TG/HDL ratio (r = −0.559), TyG index (r = −0.457), HOMA-IR (r = −0.395), and age (r = −0.327). Lower SPISE values were observed in participants with severe obesity, elevated HOMA-IR, hepatic steatosis, hypertension, and metabolic syndrome. For the detection of MetS, the SPISE index demonstrated an AUC of 0.833 (95% CI: 0.767–0.886), with 96.7% sensitivity and 62.0% specificity at a cut-off value of
- 29 June 2026
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 51 (2) , 567-576
Clinical utility of the SPISE index as an indicator of insulin resistance in pediatric obesity
Purpose: Single Point Insulin Sensitivity Estimator (SPISE) index is a lipid-based marker of insulin sensitivity, but data on its role in pediatric obesity are limited. This study evaluated its performance in identifying metabolic syndrome (MetS) and related metabolic risk factors in children and adolescents with obesity.Materials and Methods: In this retrospective study, anthropometric and laboratory data were collected, and the SPISE index was calculated based on BMI, triglyceride, and HDL cholesterol levels. Correlation analyses and receiver operating characteristic (ROC) analyses were performed to assess the association of SPISE with metabolic parameters and its performance, compared with HOMA-IR, in detecting MetS.Results: A total of 213 participants (58.7% female) with a mean age of 12.6 ± 3.2 years were included. The SPISE index showed inverse correlations with BMI SDS (r = −0.714), TG/HDL ratio (r = −0.559), TyG index (r = −0.457), HOMA-IR (r = −0.395), and age (r = −0.327). Lower SPISE values were observed in participants with severe obesity, elevated HOMA-IR, hepatic steatosis, hypertension, and metabolic syndrome. For the detection of MetS, the SPISE index demonstrated an AUC of 0.833 (95% CI: 0.767–0.886), with 96.7% sensitivity and 62.0% specificity at a cut-off value of
- Open Access
- 31 October 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (6) , 653-657
Effect of Continuous Glucose Monitoring Device Assistance on Glycemic Control of 2023 Kahramanmaraş Doublet Earthquake Survivors with Type 1 Diabetes in Adana, Turkey
Objective: The aim of this study was to investigate the effects of the devastating 2023 Kahramanmaraş earthquake on the glycemic control of children with type 1 diabetes (T1DM) in Adana, Turkey. Additionally, the study aimed to assess the impact of continuous glucose monitoring (CGM) device assistance on glycemic control after the earthquake. Materials and Methods: A retrospective study was conducted involving 134 children with T1DM receiving intensive insulin treatment. Participants were divided into 2 groups: CGM (+) (n = 58), who benefited from CGM device assistance, and CGM (−) (n = 76), who did not utilize CGM device after the earthquake. Glycated hemoglobin (HbA1c) levels were recorded before and after the earthquake. Results: Following the earthquake, the median HbA1c for all participants changed insignificantly from 8.9% to 8.6% (P = .491). However, in the CGM (+) group, HbA1c levels significantly improved post earthquake (P = .001). Conversely, the CGM (−) group experienced a deterioration in glycemic control (P = .027). A 2-way repeated measures ANOVA revealed a significant interaction effect between CGM device usage and the earthquake on HbA1c levels (F = 17.257, P < .001). Subgroup analysis based on age indicated that the effectiveness of CGM was more pronounced in adolescents (≥12 years) than in younger children (<12 years). Conclusion: This study highlights the adverse impact of the earthquake on glycemic control in children with T1DM and underscores the effectiveness of CGM in improving glycemic control, particularly among adolescents. The provision of CGM devices following the earthquake led to enhanced outcomes, mitigating the negative effects of the disaster on glycemic control. Cite this article as: Tarçın G, Dilek SÖ, Kılıç S, Ata A. Effect of continuous glucose monitoring device assistance on glycemic control of 2023 Kahramanmaraş doublet earthquake survivors with type 1 diabetes in Adana, Turkey. Turk Arch Pediatr. 2023;58(6):653-657.
- 31 October 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (6) , 653-657
Open AccessEffect of Continuous Glucose Monitoring Device Assistance on Glycemic Control of 2023 Kahramanmaraş Doublet Earthquake Survivors with Type 1 Diabetes in Adana, Turkey
Objective: The aim of this study was to investigate the effects of the devastating 2023 Kahramanmaraş earthquake on the glycemic control of children with type 1 diabetes (T1DM) in Adana, Turkey. Additionally, the study aimed to assess the impact of continuous glucose monitoring (CGM) device assistance on glycemic control after the earthquake. Materials and Methods: A retrospective study was conducted involving 134 children with T1DM receiving intensive insulin treatment. Participants were divided into 2 groups: CGM (+) (n = 58), who benefited from CGM device assistance, and CGM (−) (n = 76), who did not utilize CGM device after the earthquake. Glycated hemoglobin (HbA1c) levels were recorded before and after the earthquake. Results: Following the earthquake, the median HbA1c for all participants changed insignificantly from 8.9% to 8.6% (P = .491). However, in the CGM (+) group, HbA1c levels significantly improved post earthquake (P = .001). Conversely, the CGM (−) group experienced a deterioration in glycemic control (P = .027). A 2-way repeated measures ANOVA revealed a significant interaction effect between CGM device usage and the earthquake on HbA1c levels (F = 17.257, P < .001). Subgroup analysis based on age indicated that the effectiveness of CGM was more pronounced in adolescents (≥12 years) than in younger children (<12 years). Conclusion: This study highlights the adverse impact of the earthquake on glycemic control in children with T1DM and underscores the effectiveness of CGM in improving glycemic control, particularly among adolescents. The provision of CGM devices following the earthquake led to enhanced outcomes, mitigating the negative effects of the disaster on glycemic control. Cite this article as: Tarçın G, Dilek SÖ, Kılıç S, Ata A. Effect of continuous glucose monitoring device assistance on glycemic control of 2023 Kahramanmaraş doublet earthquake survivors with type 1 diabetes in Adana, Turkey. Turk Arch Pediatr. 2023;58(6):653-657.